Umut Ocak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Umut Ocak has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- John H. Zhang
Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, USA
16 shared publications - Pinar Eser Ocak
Department of Neurosurgery, Faculty of Medicine, Bursa Uludag University, 16059 Bursa, Turkey
16 shared publications - Jiping Tang
Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA
10 shared publications Tongyu Zhang
Department of Physiology and Pharmacology, Basic Science, School of Medicine, Loma Linda University, Risley Hall, 11041 Campus St, Loma Linda, CA, 92354, USA
9 shared publicationsWeilin Xu
Department of Physiology and Pharmacology, School of Medicine, Loma Linda University, Loma Linda, USA
9 shared publicationsJiping Tang
Department of Physiology and Pharmacology, School of Medicine, Loma Linda University, Loma Linda, USA
7 shared publications
Latest Publications
- Open Access
- 24 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 5791
Predictive Performance of Trauma Scoring Systems for Mortality in Patients with High-Energy Trauma in the Emergency Department
Background/Objectives: Early identification of high-risk trauma patients is essential for optimizing clinical decision-making and improving outcomes. Several trauma scoring systems are available, but their comparative performance for predicting early and short-term mortality remains uncertain. This study compared the prognostic performance of the Injury Severity Score (ISS), Trauma and Injury Severity Score (TRISS), Rapid Emergency Medicine Score (REMS), and Shock Index for predicting both 24-h and 28-day mortality in patients with high-energy trauma. Methods: This prospective observational study included 277 consecutive adult patients presenting with high-energy trauma to a tertiary emergency department. ISS, TRISS, REMS, and Shock Index were calculated on admission. The primary outcomes were 24-h and 28-day mortality. Discriminatory performance was assessed using receiver operating characteristic (ROC) analysis. Optimal cut-off values were determined using the Youden index, and pairwise ROC comparisons were performed using the DeLong method. An exploratory multivariable logistic regression analysis was conducted to evaluate factors associated with 28-day mortality. Results: The 24-h mortality rate was 1.4% (4/277), whereas the 28-day mortality rate was 5.4% (15/277). For predicting 28-day mortality, TRISS (AUC 0.939, 95% CI 0.898–0.979), REMS (AUC 0.907, 95% CI 0.842–0.971), and ISS (AUC 0.900, 95% CI 0.827–0.973) demonstrated excellent and comparable discrimination, whereas Shock Index showed significantly lower predictive performance (AUC 0.696, 95% CI 0.519–0.874). Pairwise DeLong comparisons demonstrated no significant differences among ISS, TRISS, and REMS, whereas Shock Index performed significantly worse than all three scores. Exploratory multivariable analysis identified antiplatelet therapy, abdominal trauma, head and neck trauma, any comorbidity, and age ≥ 65 years as factors associated with increased odds of 28-day mortality. Conclusions: ISS, TRISS, and REMS demonstrated comparable and excellent performance for predicting 28-day mortality following high-energy trauma, whereas Shock Index showed significantly lower discriminatory ability. REMS may provide a practical bedside tool for early risk assessment, while ISS and TRISS remain valuable for comprehensive prognostic evaluation. Because of the limited number of mortality events, the multivariable analysis should be considered exploratory and requires validation in larger prospective multicenter studies.
- 24 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 5791
Open AccessPredictive Performance of Trauma Scoring Systems for Mortality in Patients with High-Energy Trauma in the Emergency Department
Background/Objectives: Early identification of high-risk trauma patients is essential for optimizing clinical decision-making and improving outcomes. Several trauma scoring systems are available, but their comparative performance for predicting early and short-term mortality remains uncertain. This study compared the prognostic performance of the Injury Severity Score (ISS), Trauma and Injury Severity Score (TRISS), Rapid Emergency Medicine Score (REMS), and Shock Index for predicting both 24-h and 28-day mortality in patients with high-energy trauma. Methods: This prospective observational study included 277 consecutive adult patients presenting with high-energy trauma to a tertiary emergency department. ISS, TRISS, REMS, and Shock Index were calculated on admission. The primary outcomes were 24-h and 28-day mortality. Discriminatory performance was assessed using receiver operating characteristic (ROC) analysis. Optimal cut-off values were determined using the Youden index, and pairwise ROC comparisons were performed using the DeLong method. An exploratory multivariable logistic regression analysis was conducted to evaluate factors associated with 28-day mortality. Results: The 24-h mortality rate was 1.4% (4/277), whereas the 28-day mortality rate was 5.4% (15/277). For predicting 28-day mortality, TRISS (AUC 0.939, 95% CI 0.898–0.979), REMS (AUC 0.907, 95% CI 0.842–0.971), and ISS (AUC 0.900, 95% CI 0.827–0.973) demonstrated excellent and comparable discrimination, whereas Shock Index showed significantly lower predictive performance (AUC 0.696, 95% CI 0.519–0.874). Pairwise DeLong comparisons demonstrated no significant differences among ISS, TRISS, and REMS, whereas Shock Index performed significantly worse than all three scores. Exploratory multivariable analysis identified antiplatelet therapy, abdominal trauma, head and neck trauma, any comorbidity, and age ≥ 65 years as factors associated with increased odds of 28-day mortality. Conclusions: ISS, TRISS, and REMS demonstrated comparable and excellent performance for predicting 28-day mortality following high-energy trauma, whereas Shock Index showed significantly lower discriminatory ability. REMS may provide a practical bedside tool for early risk assessment, while ISS and TRISS remain valuable for comprehensive prognostic evaluation. Because of the limited number of mortality events, the multivariable analysis should be considered exploratory and requires validation in larger prospective multicenter studies.
- 28 June 2026
- Published by Emergency Medicine Association of Turkey in Anatolian Journal of Emergency Medicine
- Vol. 9 (2) , 91-98
Prognostic Value of Laboratory Biomarkers and Risk Scores in STEMI Patients Presenting to the Emergency Department Undergoing Manual Thrombus Aspiration
Aim: Early risk stratification in the emergency department (ED) is critical for patients presenting with ST-elevation myocardial infarction (STEMI). This study aimed to evaluate the prognostic performance of commonly used clinical risk scores (TREWS, REMS, TIMI, and C-ACS) and readily available laboratory ratios, including the D-dimer/Albumin ratio (DAR) and Blood Urea Nitrogen/Albumin ratio (BAR), for short-term outcomes in STEMI patients presenting to the ED who subsequently underwent manual thrombus aspiration (MTA) during percutaneous coronary intervention (PCI).Material and Methods: This prospective, single-center study included consecutive STEMI patients presenting to the ED between February 2023 and January 2024. Patients who underwent MTA during PCI were analyzed. The ability of clinical scores and laboratory ratios obtained during the initial ED evaluation to predict 28-day all-cause mortality, recurrent acute coronary syndrome (ACS), and stroke was assessed using receiver operating characteristic (ROC) curve analysis.Results: Among 363 STEMI patients, 30 (8.3%) underwent MTA. MTA was more frequently performed in patients with anterolateral and posterolateral STEMI. Significant differences were observed in age, REMS, and C-ACS scores between patients who did and did not undergo MTA. The TIMI score differed significantly across STEMI localization subgroups. BAR demonstrated excellent prognostic performance for 28-day mortality (AUC = 0.889; 95% CI: 0.766–1.000; p < 0.05). None of the evaluated scores or laboratory ratios reliably predicted recurrent ACS or stroke.Conclusion: Among the evaluated laboratory biomarkers and clinical scores, BAR demonstrated the highest prognostic performance for predicting 28-day mortality in STEMI patients undergoing MTA. These findings suggest that BAR, a simple and rapidly available laboratory parameter, may assist emergency physicians in early risk stratification of high-risk STEMI patients, whereas traditional risk scores showed limited utility for predicting short-term non-fatal outcomes.
- 28 June 2026
- Published by Emergency Medicine Association of Turkey in Anatolian Journal of Emergency Medicine
- Vol. 9 (2) , 91-98
Prognostic Value of Laboratory Biomarkers and Risk Scores in STEMI Patients Presenting to the Emergency Department Undergoing Manual Thrombus Aspiration
Aim: Early risk stratification in the emergency department (ED) is critical for patients presenting with ST-elevation myocardial infarction (STEMI). This study aimed to evaluate the prognostic performance of commonly used clinical risk scores (TREWS, REMS, TIMI, and C-ACS) and readily available laboratory ratios, including the D-dimer/Albumin ratio (DAR) and Blood Urea Nitrogen/Albumin ratio (BAR), for short-term outcomes in STEMI patients presenting to the ED who subsequently underwent manual thrombus aspiration (MTA) during percutaneous coronary intervention (PCI).Material and Methods: This prospective, single-center study included consecutive STEMI patients presenting to the ED between February 2023 and January 2024. Patients who underwent MTA during PCI were analyzed. The ability of clinical scores and laboratory ratios obtained during the initial ED evaluation to predict 28-day all-cause mortality, recurrent acute coronary syndrome (ACS), and stroke was assessed using receiver operating characteristic (ROC) curve analysis.Results: Among 363 STEMI patients, 30 (8.3%) underwent MTA. MTA was more frequently performed in patients with anterolateral and posterolateral STEMI. Significant differences were observed in age, REMS, and C-ACS scores between patients who did and did not undergo MTA. The TIMI score differed significantly across STEMI localization subgroups. BAR demonstrated excellent prognostic performance for 28-day mortality (AUC = 0.889; 95% CI: 0.766–1.000; p < 0.05). None of the evaluated scores or laboratory ratios reliably predicted recurrent ACS or stroke.Conclusion: Among the evaluated laboratory biomarkers and clinical scores, BAR demonstrated the highest prognostic performance for predicting 28-day mortality in STEMI patients undergoing MTA. These findings suggest that BAR, a simple and rapidly available laboratory parameter, may assist emergency physicians in early risk stratification of high-risk STEMI patients, whereas traditional risk scores showed limited utility for predicting short-term non-fatal outcomes.
- Open Access
- 30 April 2024
- Published by Eurasian Journal of Toxicology, Emergency Physicians Association of Turkey in Eurasian Journal of Toxicology
- Vol. 6 (1) , 15-16
One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome
Sympathomimetic syndromes are rare medical conditions involving complex clinical pictures caused by substances that have a stimulatory effect on the sympathetic nervous system or have similar effects to the sympathetic nervous system. In this case report, the clinical manifestations of sympathomimetic syndromes, the diagnostic process, treatment strategies and the difficulties encountered especially in emergency medicine will be reviewed.
- 30 April 2024
- Published by Eurasian Journal of Toxicology, Emergency Physicians Association of Turkey in Eurasian Journal of Toxicology
- Vol. 6 (1) , 15-16
Open AccessOne Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome
Sympathomimetic syndromes are rare medical conditions involving complex clinical pictures caused by substances that have a stimulatory effect on the sympathetic nervous system or have similar effects to the sympathetic nervous system. In this case report, the clinical manifestations of sympathomimetic syndromes, the diagnostic process, treatment strategies and the difficulties encountered especially in emergency medicine will be reviewed.
- Open Access
- 29 January 2024
- Published by Sağlık Bilimleri Üniversitesi, Bursa Tıp Fakültesi in Journal of Bursa Faculty of Medicine
- Vol. 2 (1) , 27-29
An Interesting Case of Posterior Reversible Encephalopathy Syndrome
Posterior Reversible Encephalopathy Syndrome (PRES) is a special type of cerebrovascular disease defined by clinical and imaging findings. The onset of PRES typically includes acute or subacute headaches, visual impairment, seizures, focal neurological defects and nonspecific symptoms such as nausea and vomiting. The purpose of this case report is to present the characteristics of these diseases in a pregnant patient with both preeclampsia and PRES, and to contribute to the literature by discussing the differential diagnosis.
- 29 January 2024
- Published by Sağlık Bilimleri Üniversitesi, Bursa Tıp Fakültesi in Journal of Bursa Faculty of Medicine
- Vol. 2 (1) , 27-29
Open AccessAn Interesting Case of Posterior Reversible Encephalopathy Syndrome
Posterior Reversible Encephalopathy Syndrome (PRES) is a special type of cerebrovascular disease defined by clinical and imaging findings. The onset of PRES typically includes acute or subacute headaches, visual impairment, seizures, focal neurological defects and nonspecific symptoms such as nausea and vomiting. The purpose of this case report is to present the characteristics of these diseases in a pregnant patient with both preeclampsia and PRES, and to contribute to the literature by discussing the differential diagnosis.
- 31 December 2023
- Published by Eurasian Journal of Toxicology, Emergency Physicians Association of Turkey in Eurasian Journal of Toxicology
- Vol. 5 (3) , 31-32
Intracranial Bleeding in Methanol Intoxication Case
Methyl alcohol, which is mostly used in the industrial sector, is also widely used in our country to obtain cheap drinks. It is a colorless, volatile liquid with a distinctive odor. Even 8-10 ml of methanol taken into the body from outside is toxic. Approximately 25-30 ml of methanol can cause poisoning that can lead to permanent blindness. The best method for the definitive diagnosis of methyl alcohol poisoning is to measure the methanol level in the blood. Patients may develop headache, central nervous system depression, coma and seizure. Imaging is recommended in patients with altered consciousness. Putaminal necrosis and intracranial hemorrhage (SAH, putaminal intraparenchymal hemorrhage) may develop in these patients. Our case is a 50-year-old male patient with a history of constant homemade alcohol consumption. The patient was brought with complaints of visual impairment and confusion after drinking alcohol. Basal ganglia hemorrhage was detected on the patient's cranial tomography. The patient, who was admitted to intensive care, deteriorated and died on the 4th day of his treatment. Morbidity and mortality rates can be very high in patients presenting with suspected methanol intoxication. Therefore, we wanted to emphasize the importance of early diagnosis and treatment.
- 31 December 2023
- Published by Eurasian Journal of Toxicology, Emergency Physicians Association of Turkey in Eurasian Journal of Toxicology
- Vol. 5 (3) , 31-32
Intracranial Bleeding in Methanol Intoxication Case
Methyl alcohol, which is mostly used in the industrial sector, is also widely used in our country to obtain cheap drinks. It is a colorless, volatile liquid with a distinctive odor. Even 8-10 ml of methanol taken into the body from outside is toxic. Approximately 25-30 ml of methanol can cause poisoning that can lead to permanent blindness. The best method for the definitive diagnosis of methyl alcohol poisoning is to measure the methanol level in the blood. Patients may develop headache, central nervous system depression, coma and seizure. Imaging is recommended in patients with altered consciousness. Putaminal necrosis and intracranial hemorrhage (SAH, putaminal intraparenchymal hemorrhage) may develop in these patients. Our case is a 50-year-old male patient with a history of constant homemade alcohol consumption. The patient was brought with complaints of visual impairment and confusion after drinking alcohol. Basal ganglia hemorrhage was detected on the patient's cranial tomography. The patient, who was admitted to intensive care, deteriorated and died on the 4th day of his treatment. Morbidity and mortality rates can be very high in patients presenting with suspected methanol intoxication. Therefore, we wanted to emphasize the importance of early diagnosis and treatment.
- Open Access
- 30 September 2023
- Published by MediHealth Academy in Intercontinental Journal of Emergency Medicine
- Vol. 1 (3) , 55-56
Streptococcus pneumonia-induced meningoencephalitis presenting as rhinitis and acute stroke!
Meningoencephalitis, a potentially fatal condition marked by inflammation of the brain and medulla spinalis, can exhibit a wide range of symptoms. Streptococcus pneumonia, a gram-positive bacterium, is a common bacterial factor for this condition which can be challenging to diagnose due to its ability to resemble other diseases. Here, we report a case of a 48-years-old female with pneumococcal meningoencephalitis who presented with the symptoms of rhinitis, which is inflammation of the nasal passages and acute stroke treated with intravenous antibiotics and eventually admitted to the hospital. In this case report we would like to highlight that early diagnosis and proper treatment of meningoencephalitis are essential to improve patient outcomes, and physicians must recognize the central nervous system infections mimicking other diseases along with appropriate diagnostic approaches and management strategies.
- 30 September 2023
- Published by MediHealth Academy in Intercontinental Journal of Emergency Medicine
- Vol. 1 (3) , 55-56
Open AccessStreptococcus pneumonia-induced meningoencephalitis presenting as rhinitis and acute stroke!
Meningoencephalitis, a potentially fatal condition marked by inflammation of the brain and medulla spinalis, can exhibit a wide range of symptoms. Streptococcus pneumonia, a gram-positive bacterium, is a common bacterial factor for this condition which can be challenging to diagnose due to its ability to resemble other diseases. Here, we report a case of a 48-years-old female with pneumococcal meningoencephalitis who presented with the symptoms of rhinitis, which is inflammation of the nasal passages and acute stroke treated with intravenous antibiotics and eventually admitted to the hospital. In this case report we would like to highlight that early diagnosis and proper treatment of meningoencephalitis are essential to improve patient outcomes, and physicians must recognize the central nervous system infections mimicking other diseases along with appropriate diagnostic approaches and management strategies.
- Open Access
- 14 August 2023
- Published by Elsevier in Brain Hemorrhages
- Vol. 5 (1) , 46-49
Falx interhemispheric subdural hematoma in a hypertensive patient with urticaria: A case report
- 14 August 2023
- Published by Elsevier in Brain Hemorrhages
- Vol. 5 (1) , 46-49
Open AccessFalx interhemispheric subdural hematoma in a hypertensive patient with urticaria: A case report
- Open Access
- 1 September 2022
- Published by KEAI Publishing in Brain Hemorrhages
- Vol. 3 (3) , 108-110
Analysis of echocardiographic characteristics in patients with acute intracerebral hemorrhage
- 1 September 2022
- Published by KEAI Publishing in Brain Hemorrhages
- Vol. 3 (3) , 108-110
Open AccessAnalysis of echocardiographic characteristics in patients with acute intracerebral hemorrhage
- Open Access
- 21 January 2022
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 19 (1) , 1-17
Met-RANTES preserves the blood–brain barrier through inhibiting CCR1/SRC/Rac1 pathway after intracerebral hemorrhage in mice
Background: C–C chemokine receptor type 1 (CCR1) and its endogenous ligand, CCL5, participate in the pathogenesis of neuroinflammatory diseases. However, much remains unknown regarding CCL5/CCR1 signaling in blood–brain barrier (BBB) permeability after intracerebral hemorrhage (ICH).Methods: A total of 250 CD1 male mice were used and ICH was induced via autologous whole blood injection. Either Met-RANTES, a selective CCR1 antagonist, or Met-RANTES combined with a Rac1 CRISPR activator was administered to the mice 1 h after ICH. Post-ICH assessments included neurobehavioral tests, brain water content, BBB integrity, hematoma volume, Western blot, and immunofluorescence staining. The CCR1 ligand, rCCL5, and SRC CRISPR knockout in naïve mice were used to further elucidate detrimental CCL5/CCR1/SRC signaling.Results: Brain endogenous CCR1 and CCL5 were upregulated after ICH in mice with a peak at 24 h, and CCR1 was expressed in endothelial cells, astrocytes, and neurons. Met-R treatment reduced brain edema and neurobehavioral impairment, as well as preserved BBB integrity and tight junction protein expression in ICH mice. Met-R treatment decreased expression of p-SRC, Rac1, albumin, and MMP9, but increased claudin-5, occludin, and ZO-1 tight junction proteins after ICH. These effects were regressed using the Rac1 CRISPR activator. Administration of rCCL5 in naïve mice increased expression of p-SRC, Rac1, albumin, and MMP9, but decreased levels of claudin-5, occludin, and ZO-1 tight junction proteins. These effects in naïve mice were reversed with SRC CRISPR (KO).Conclusions: Our findings demonstrate that CCR5 inhibition by Met-R improves neurological deficits after ICH by preserving BBB integrity through inhibiting CCR1/SRC/Rac1 signaling pathway in mice. Thus, Met-R has therapeutic potential in the management of ICH patients.
- 21 January 2022
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 19 (1) , 1-17
Open AccessMet-RANTES preserves the blood–brain barrier through inhibiting CCR1/SRC/Rac1 pathway after intracerebral hemorrhage in mice
Background: C–C chemokine receptor type 1 (CCR1) and its endogenous ligand, CCL5, participate in the pathogenesis of neuroinflammatory diseases. However, much remains unknown regarding CCL5/CCR1 signaling in blood–brain barrier (BBB) permeability after intracerebral hemorrhage (ICH).Methods: A total of 250 CD1 male mice were used and ICH was induced via autologous whole blood injection. Either Met-RANTES, a selective CCR1 antagonist, or Met-RANTES combined with a Rac1 CRISPR activator was administered to the mice 1 h after ICH. Post-ICH assessments included neurobehavioral tests, brain water content, BBB integrity, hematoma volume, Western blot, and immunofluorescence staining. The CCR1 ligand, rCCL5, and SRC CRISPR knockout in naïve mice were used to further elucidate detrimental CCL5/CCR1/SRC signaling.Results: Brain endogenous CCR1 and CCL5 were upregulated after ICH in mice with a peak at 24 h, and CCR1 was expressed in endothelial cells, astrocytes, and neurons. Met-R treatment reduced brain edema and neurobehavioral impairment, as well as preserved BBB integrity and tight junction protein expression in ICH mice. Met-R treatment decreased expression of p-SRC, Rac1, albumin, and MMP9, but increased claudin-5, occludin, and ZO-1 tight junction proteins after ICH. These effects were regressed using the Rac1 CRISPR activator. Administration of rCCL5 in naïve mice increased expression of p-SRC, Rac1, albumin, and MMP9, but decreased levels of claudin-5, occludin, and ZO-1 tight junction proteins. These effects in naïve mice were reversed with SRC CRISPR (KO).Conclusions: Our findings demonstrate that CCR5 inhibition by Met-R improves neurological deficits after ICH by preserving BBB integrity through inhibiting CCR1/SRC/Rac1 signaling pathway in mice. Thus, Met-R has therapeutic potential in the management of ICH patients.
- Top Cited PapersOpen Access
- 1 January 2021
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (2) , 522-539
Melanocortin 1 receptor attenuates early brain injury following subarachnoid hemorrhage by controlling mitochondrial metabolism via AMPK/SIRT1/PGC-1α pathway in rats
Mitochondria-mediated oxidative stress and apoptosis contribute greatly to early brain injury (EBI) following subarachnoid hemorrhage (SAH). This study hypothesized that activation of melanocortin 1 receptor (MC1R), using BMS-470539, attenuates EBI by controlling mitochondrial metabolism after SAH.
- 1 January 2021
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (2) , 522-539
Top Cited PapersOpen AccessMelanocortin 1 receptor attenuates early brain injury following subarachnoid hemorrhage by controlling mitochondrial metabolism via AMPK/SIRT1/PGC-1α pathway in rats
Mitochondria-mediated oxidative stress and apoptosis contribute greatly to early brain injury (EBI) following subarachnoid hemorrhage (SAH). This study hypothesized that activation of melanocortin 1 receptor (MC1R), using BMS-470539, attenuates EBI by controlling mitochondrial metabolism after SAH.